This will be just like RCEL was last year, the timing is exact except FOMX has far more catalysts after March than RCEL did especially the PDUFA in June and RCEL did not have an international partnership to be announced either where they would be getting up front money as they were already marketing overseas.
With MNLO they do add 4 other significant catalysts in the first half of 2020 where there will literally be one almost every 2 weeks. That's what keeps any biotech going catalysts which start with commercial launch in January. When there is a chance of no catalyst for a bit these things get flipped out of and shorted it is just fact, has zero to do with anything else.
Like RCEL this will start trending up after January commercial launch and will just steadily rise look at the chart for RCEL last year from January and you will see the future with this only difference this will be starting higher that the 1'1 but it sill exactly the same period. But, lets just see.
Peace out.
News 
Market Data 
Discover 
